BAM
CLB icon

Belpointe Asset Management’s Core Laboratories CLB Stock Holding History

Belpointe Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22
Closed -$485 – 1065
2023
Q1 		$485 Hold
22
– – ﹤0.01% 3596
2022
Q4 		$446 Buy
+22
New +$426 ﹤0.01% 3564

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Belpointe Asset Management's CLB Position: Q2 2023 in Review

Belpointe Asset Management sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 22 shares — an estimated $485 sold.

Belpointe Asset Management first reported a position in CLB in Q4 2022 and held it in 2 quarters. The position peaked at $485 in Q1 2023. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

  • Belpointe Asset Management reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 22 Core Laboratories shares in Q2 2023, an estimated $485.
  • Belpointe Asset Management first reported a position in Core Laboratories in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Core Laboratories position peaked at $485 in Q1 2023.
  • 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.